Five numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 10 other studies
the abstract, start to end
… in the placebo group (hazard ratio, 0.79; 95% confidence interval [CI], …
… in the placebo group (hazard ratio, 0.49; 95% CI, 0.27 to 0.92); nonfatal myocardial infarction, 37 of 1591 patients (2.3%) and 31 of 1592 (1.9%), respectively (hazard ratio, 1.18; 95% CI, 0.73 to 1.90); and nonfatal stroke, 12 of 1591 patients (0.8%) and 16 of 1592 (1.0%), respectively (hazard ratio, 0.74; 95% CI, 0.35 to 1.57).
… in the placebo group (hazard ratio, 0.51; 95% CI, 0.31 to 0.84).
← favours treatmentfavours comparator →
could be chanceCardiovascular events
HR 0.790.57–1.11
Cardiovascular events
HR 0.490.27–0.92
Cardiovascular events
HR 1.180.73–1.90
Cardiovascular events
HR 0.740.35–1.57
All-cause mortality
HR 0.510.31–0.84
GLP-1 receptor agonistsCardiovascular eventsAll-cause mortality
GLP-1 receptor agonists × cardiovascular eventshelps?mixed
unlikelylikely
0.500.78 without it
GLP-1 receptor agonists × all-cause mortalityhelps?replicated
unlikelylikely
0.881.00 without it
← favours treatmentfavours comparator →
1 / 5